These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

920 related articles for article (PubMed ID: 17822324)

  • 1. Could changes in the regulation of the PI3K/PKB/Akt signaling pathway and cell cycle be involved in astrocytic tumor pathogenesis and progression?
    Hlobilkova A; Ehrmann J; Sedlakova E; Krejci V; Knizetova P; Fiuraskova M; Kala M; Kalita O; Kolar Z
    Neoplasma; 2007; 54(4):334-41. PubMed ID: 17822324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression of P21 WAF1/CIP1 in human astrocytomas in correlating with P53, MDM2, and cellular proliferation index].
    Xu QZ; Liu F; Lu DH; Yu SZ; Yang H
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Aug; 23(4):341-5. PubMed ID: 12940073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S; Chrétien AS; Ramacci C; Rouyer M; Becuwe P; Merlin JL
    Oncol Rep; 2009 Mar; 21(3):731-5. PubMed ID: 19212633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of complex protein kinase B signalling pathways in human prostate cancer samples.
    Jendrossek V; Henkel M; Hennenlotter J; Vogel U; Ganswindt U; Müller I; Handrick R; Anastasiadis AG; Kuczyk M; Stenzl A; Belka C
    BJU Int; 2008 Aug; 102(3):371-82. PubMed ID: 18476967
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumour suppressor PTEN regulates cell cycle and protein kinase B/Akt pathway in breast cancer cells.
    Hlobilkova A; Knillova J; Svachova M; Skypalova P; Krystof V; Kolar Z
    Anticancer Res; 2006; 26(2A):1015-22. PubMed ID: 16619501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of zinc deficiency on Akt-Mdm2-p53 and Akt-p21 signaling axes in normal and malignant human prostate cells.
    Han CT; Schoene NW; Lei KY
    Am J Physiol Cell Physiol; 2009 Nov; 297(5):C1188-99. PubMed ID: 19657064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PI3K/AKT pathway activation in bladder carcinogenesis.
    Calderaro J; Rebouissou S; de Koning L; Masmoudi A; Hérault A; Dubois T; Maille P; Soyeux P; Sibony M; de la Taille A; Vordos D; Lebret T; Radvanyi F; Allory Y
    Int J Cancer; 2014 Apr; 134(8):1776-84. PubMed ID: 24122582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Temporal PTEN inactivation causes proliferation of saphenous vein smooth muscle cells of human CABG conduits.
    Mitra AK; Jia G; Gangahar DM; Agrawal DK
    J Cell Mol Med; 2009 Jan; 13(1):177-87. PubMed ID: 18363844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of 1p/19q status by fluorescence in situ hybridization assay: A comparative study in oligodendroglial, mixed oligoastrocytic and astrocytic tumors.
    Shukla B; Agarwal S; Suri V; Pathak P; Sharma MC; Gupta D; Sharma BS; Suri A; Halder A; Sarkar C
    Neurol India; 2009; 57(5):559-66. PubMed ID: 19934553
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ganglioside GM3 modulates tumor suppressor PTEN-mediated cell cycle progression--transcriptional induction of p21(WAF1) and p27(kip1) by inhibition of PI-3K/AKT pathway.
    Choi HJ; Chung TW; Kang SK; Lee YC; Ko JH; Kim JG; Kim CH
    Glycobiology; 2006 Jul; 16(7):573-83. PubMed ID: 16574813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Akt/protein kinase B overexpression as an accurate prognostic marker in adult diffuse astrocytoma.
    Matsutani T; Nagai Y; Mine S; Murai H; Saeki N; Iwadate Y
    Acta Neurochir (Wien); 2009 Mar; 151(3):263-8; discussion 268. PubMed ID: 19240976
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple defects in negative regulation of the PKB/Akt pathway sensitise human cancer cells to the antiproliferative effect of non-steroidal anti-inflammatory drugs.
    Lincová E; Hampl A; Pernicová Z; Starsíchová A; Krcmár P; Machala M; Kozubík A; Soucek K
    Biochem Pharmacol; 2009 Sep; 78(6):561-72. PubMed ID: 19433066
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of PI3K is associated with reduced survival in renal cell carcinoma.
    Merseburger AS; Hennenlotter J; Kuehs U; Simon P; Kruck S; Koch E; Stenzl A; Kuczyk MA
    Urol Int; 2008; 80(4):372-7. PubMed ID: 18587247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Research on miR-126 in glioma targeted regulation of PTEN/PI3K/Akt and MDM2-p53 pathways.
    Chen SR; Cai WP; Dai XJ; Guo AS; Chen HP; Lin GS; Lin RS
    Eur Rev Med Pharmacol Sci; 2019 Apr; 23(8):3461-3470. PubMed ID: 31081101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-response transition from cell cycle arrest to apoptosis with selective degradation of Mdm2 and p21WAF1/CIP1 in response to the novel anticancer agent, aminoflavone (NSC 686,288).
    Meng LH; Kohn KW; Pommier Y
    Oncogene; 2007 Jul; 26(33):4806-16. PubMed ID: 17297446
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXO target gene CTDSP2 regulates cell cycle progression through Ras and p21(Cip1/Waf1).
    Kloet DE; Polderman PE; Eijkelenboom A; Smits LM; van Triest MH; van den Berg MC; Groot Koerkamp MJ; van Leenen D; Lijnzaad P; Holstege FC; Burgering BM
    Biochem J; 2015 Jul; 469(2):289-98. PubMed ID: 25990325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of cell cycle regulators in gliomatosis cerebri.
    Mawrin C; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Deimling A; Stoltenburg-Didinge G; Bornemann A; Romeike B; Sellhaus B; Dietzmann K
    J Neurooncol; 2005 Apr; 72(2):115-22. PubMed ID: 15925990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidermal growth factor receptor, protein kinase B/Akt, and glioma response to erlotinib.
    Haas-Kogan DA; Prados MD; Tihan T; Eberhard DA; Jelluma N; Arvold ND; Baumber R; Lamborn KR; Kapadia A; Malec M; Berger MS; Stokoe D
    J Natl Cancer Inst; 2005 Jun; 97(12):880-7. PubMed ID: 15956649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The phosphatidylinositol 3-kinase/AKT signal transduction pathway plays a critical role in the expression of p21WAF1/CIP1/SDI1 induced by cisplatin and paclitaxel.
    Mitsuuchi Y; Johnson SW; Selvakumaran M; Williams SJ; Hamilton TC; Testa JR
    Cancer Res; 2000 Oct; 60(19):5390-4. PubMed ID: 11034077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Astrocyte-specific expression of activated p21-ras results in malignant astrocytoma formation in a transgenic mouse model of human gliomas.
    Ding H; Roncari L; Shannon P; Wu X; Lau N; Karaskova J; Gutmann DH; Squire JA; Nagy A; Guha A
    Cancer Res; 2001 May; 61(9):3826-36. PubMed ID: 11325859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 46.